{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:37:13Z","timestamp":1747204633282,"version":"3.40.5"},"posted":{"date-parts":[[2023,6,15]]},"group-title":"In Review","reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,16]]},"abstract":"<title>Abstract<\/title>\n        <p>Purpose\n Hyperglycemia is associated with abnormalities of lipoproteins. The aim of this study was to analyze, in patients with Type 1 Diabetes (T1D), the association of glycemic control with lipid profile, focusing on glycemic variability and time in range obtained from Continuous Glucose Monitoring (CGM).\nMethods\n We performed a retrospective cohort in patients with T1D. We analyzed clinical parameters, HbA1c, CGM and lipid profile in two moments 6 to 18 months apart. We evaluated the association of HbA1c and CGM metrics with lipid profile in cross-sectional (n\u2009=\u2009242) and longitudinal (n\u2009=\u200990) analyses.\nResults\n The mean age of the study population was 36.6\u2009\u00b1\u200912.6 years, 51.7% were male, and the mean diabetes duration was 16.8\u2009\u00b1\u200910.3 years. In the cross-sectional analysis, higher HbA1c, higher glucose management indicator (GMI), higher time above range and lower time in range were associated with higher triglyceride levels. In the longitudinal analysis, an increase in time below range was associated with a decrease of HDL cholesterol. In both analyses, an increase in the coefficient of variability (CV) was associated with a significant decrease of HDL cholesterol. HbA1c and CGM were not associated with total cholesterol or LDL cholesterol.\nConclusions\n We observed a negative association between CV and HDL cholesterol levels and a positive association between hyperglycemia metrics and triglyceride levels. These findings suggest that CGM parameters may be a helpful tool to guide the improvement of both glycemic control and lipid profile in T1D.<\/p>","DOI":"10.21203\/rs.3.rs-2943647\/v1","type":"posted-content","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T11:49:16Z","timestamp":1686829756000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Glycemic Variability and Time in Range with Lipid Profile in Type 1 Diabetes"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-0047","authenticated-orcid":false,"given":"Mariana Isabel Salsa","family":"Castelo","sequence":"first","affiliation":[{"name":"University of Porto Faculty of  Medicine: Universidade do Porto Faculdade de Medicina"}]},{"given":"Celestino","family":"Neves","sequence":"additional","affiliation":[{"name":"Sao Joao Hospital: Centro Hospitalar Universitario de Sao Joao"}]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[{"name":"Sao Joao Hospital: Centro Hospitalar Universitario de Sao Joao"}]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Sao Joao Hospital: Centro Hospitalar Universitario de Sao Joao"}]}],"member":"297","reference":[{"issue":"21","key":"ref1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind M","year":"2014","unstructured":"M. Lind et al., Glycemic control and excess mortality in type 1 diabetes. N Engl. J. Med. 371(21), 1972\u20131982 (2014)","journal-title":"N Engl. J. Med."},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":".a.C.T.E.o.D.I.a.C.D.E.R., Risk Factors for Cardiovascular Disease in Type 1 Diabetes","volume":"65","author":"Group DC","year":"2016","unstructured":"D.C. Group, .a.C.T.E.o.D.I.a.C.D.E.R., Risk Factors for Cardiovascular Disease in Type 1 Diabetes. Diabetes. 65(5), 1370\u20131379 (2016)","journal-title":"Diabetes"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tem.2020.01.015","article-title":"Dyslipidemia in Type 1 Diabetes: AMaskedDanger","volume":"31","author":"Verg\u00e8s B","year":"2020","unstructured":"B. Verg\u00e8s, Dyslipidemia in Type 1 Diabetes: AMaskedDanger. Trends Endocrinol. Metab. 31(6), 422\u2013434 (2020)","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/dc08-1775","article-title":"Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study","volume":"32","author":"Guy J","year":"2009","unstructured":"J. Guy et al., Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study. Diabetes Care. 32(3), 416\u2013420 (2009)","journal-title":"Diabetes Care"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1007\/s00125-010-1886-6","article-title":"Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication","volume":"53","author":"Maahs DM","year":"2010","unstructured":"D.M. Maahs et al., Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication. Diabetologia. 53(12), 2518\u20132525 (2010)","journal-title":"Diabetologia"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International Consensus on Use of Continuous Glucose Monitoring","volume":"40","author":"Danne T","year":"2017","unstructured":"T. Danne et al., International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 40(12), 1631\u20131640 (2017)","journal-title":"Diabetes Care"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management","volume":"7","author":"Group IHS","year":"2019","unstructured":"I.H.S. Group, Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 7(5), 385\u2013396 (2019)","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","article-title":"Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level","volume":"23","author":"Temelkova-Kurktschiev TS","year":"2000","unstructured":"T.S. Temelkova-Kurktschiev et al., Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 23(12), 1830\u20131834 (2000)","journal-title":"Diabetes Care"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071477","article-title":"Identifying Glycemic Variability in Diabetes Patient Cohorts and Evaluating Disease Outcomes","volume":"10","author":"Nwadiugwu MC","year":"2021","unstructured":"M.C. Nwadiugwu et al., Identifying Glycemic Variability in Diabetes Patient Cohorts and Evaluating Disease Outcomes. J. Clin. Med., 2021. 10(7)","journal-title":"J. Clin. Med."},{"issue":"Supplement1","key":"ref10","first-page":"S83","article-title":"Glycemic Targets: Standards of Medical Care in Diabetes\u20142022","volume":"45","author":"Committee ADAPP","year":"2021","unstructured":"A.D.A.P.P. Committee, Glycemic Targets: Standards of Medical Care in Diabetes\u20142022. Diabetes Care. 45(Supplement1), S83\u2013S96 (2021)","journal-title":"Diabetes Care"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.103.3.346","article-title":"Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors","volume":"103","author":"Haffner SM","year":"2001","unstructured":"S.M. Haffner, Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. Circulation. 103(3), 346\u2013347 (2001)","journal-title":"Circulation"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.CIR.0000134501.57864.66","article-title":"Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus","volume":"110","author":"Esposito K","year":"2004","unstructured":"K. Esposito et al., Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation. 110(2), 214\u2013219 (2004)","journal-title":"Circulation"},{"issue":"14","key":"ref13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier L","year":"2006","unstructured":"L. Monnier et al., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Jama. 295(14), 1681\u20131687 (2006)","journal-title":"Jama"},{"issue":"6","key":"ref14","first-page":"1659","article-title":"Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data","volume":"79","author":"Cox DJ","year":"1994","unstructured":"D.J. Cox et al., Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J. Clin. Endocrinol. Metab. 79(6), 1659\u20131662 (1994)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"ref15","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/archinte.160.18.2756","article-title":"Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control","volume":"160","author":"P\u00e9rez A","year":"2000","unstructured":"A. P\u00e9rez et al., Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control. Arch. Intern. Med. 160(18), 2756\u20132762 (2000)","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12902-021-00863-x","article-title":"The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study","volume":"21","author":"Huang R","year":"2021","unstructured":"R. Huang, L. Yan, Y. Lei, The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study. BMC Endocr. Disord. 21(1), 198 (2021)","journal-title":"BMC Endocr. Disord"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.diabet.2009.04.004","article-title":"Lipid disorders in type 1 diabetes","volume":"35","author":"Verg\u00e8s B","year":"2009","unstructured":"B. Verg\u00e8s, Lipid disorders in type 1 diabetes. Diabetes Metab. 35(5), 353\u2013360 (2009)","journal-title":"Diabetes Metab."},{"issue":"7","key":"ref18","article-title":"Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities","volume":"9","author":"O'Brien ST","year":"2021","unstructured":"S.T. O'Brien, O.M. Neylon, T. O'Brien, Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities. Biomedicines, 2021. 9(7)","journal-title":"Biomedicines"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Diabetic Dyslipidemia: Causes and Consequences","volume":"86","author":"Goldberg IJ","year":"2001","unstructured":"I.J. Goldberg, Diabetic Dyslipidemia: Causes and Consequences. J. Clin. Endocrinol. Metabolism. 86(3), 965\u2013971 (2001)","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2337\/diacare.19.7.689","article-title":"Cardiovascular Disease and Its Risk Factors in IDDM in Europe","volume":"19","author":"Koivisto VA","year":"1996","unstructured":"V.A. Koivisto et al., Cardiovascular Disease and Its Risk Factors in IDDM in Europe. Diabetes Care. 19(7), 689\u2013697 (1996)","journal-title":"Diabetes Care"},{"issue":"Supplement1","key":"ref21","first-page":"S144","article-title":"Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes\u20142022","volume":"45","author":"Committee ADAPP","year":"2021","unstructured":"A.D.A.P.P. Committee, Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes\u20142022. Diabetes Care. 45(Supplement1), S144\u2013S174 (2021)","journal-title":"Diabetes Care"},{"volume-title":"National Consensus in the use of the Flash Glucose Monitoring System in Portugal","author":"Cardoso H","key":"ref22","unstructured":"H. Cardoso et al., National Consensus in the use of the Flash Glucose Monitoring System in Portugal. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 2019(1)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2943647\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2943647\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T16:20:26Z","timestamp":1702311626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2943647\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":22,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2943647\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s12020-023-03464-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,6,15]]},"subtype":"preprint"}}